"Mr. Moscato said, “I am quite excited as we enter this pivotal week in which we expect to make progress on several strategic initiatives that should allow us to declare the 1:1 dividend on Thursday, June 20th, pending the completion of certain documents and agreements. Nothing makes me happier than to keep my word to our valuable shareholders who gave me permission to clean up the company and reorganize our operations to where we are today."

"At the end this week, I will be able to provide our shareholders with a complete, company-wide update, as well as additional details pertaining to the merger and spin out of NuGenerex Immuno-Oncology, Inc."

" It is a very exciting time for Generex as we near the completion of Phase 3 in our overall plan, which will be fully completed with an up-listing to either NASDAQ or the NYSE. I look forward to speaking with our shareholders on Friday morning.”

Add Olaragen Therapeutix, new MSO model, Regentys ECMHO, and NuGenerex Health.

How could you not anticipate this CC on 6/21? The critical issue for all of these is time frames. If Joe can flesh those out, the CC will be a raging success.